Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-10-31T23:36:31.532Z Has data issue: false hasContentIssue false

Control of an Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Australia after Introduction of Environmental Cleaning with a Commercial Oxidizing Disinfectant

Published online by Cambridge University Press:  02 January 2015

Michelle Doidge
Affiliation:
Department of Infectious Diseases, Brisbane, Australia
Anthony M. Allworth
Affiliation:
Department of Infectious Diseases, Brisbane, Australia
Marion Woods
Affiliation:
Department of Infectious Diseases, Brisbane, Australia
Penelope Marshall
Affiliation:
Department of Infectious Diseases, Brisbane, Australia
Michael Terry
Affiliation:
Department of Infectious Diseases, Brisbane, Australia
Kathryn O'Brien
Affiliation:
Department of Infectious Diseases, Brisbane, Australia
Hwee Mian Goh
Affiliation:
Royal Brisbane and Women's Hospital, and the School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Australia
Narelle George
Affiliation:
Central Microbiology Laboratory, Pathology Queensland, Brisbane, Australia
Graeme R. Nimmo
Affiliation:
Central Microbiology Laboratory, Pathology Queensland, Brisbane, Australia
Mark A. Schembri
Affiliation:
Royal Brisbane and Women's Hospital, and the School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Australia
Jeffrey Lipman
Affiliation:
Department of Critical Care Medicine, Brisbane, Australia
David L. Paterson*
Affiliation:
Department of Infectious Diseases, Brisbane, Australia Central Microbiology Laboratory, Pathology Queensland, Brisbane, Australia Centre for Healthcare-Related Infection Surveillance and Prevention, Brisbane, Australia University of Queensland Centre for Clinical Research, Brisbane, Australia
*
8th Fl, UQCCR Bldg, Royal Brisbane and Women's Hospital, Brisbane 4029, Australia (david.antibiotics@gmail.com)

Abstract

In the midst of an outbreak, carbapenem-resistant Acinetobacter baumannii was grown from samples of multiple environmental sites in an intensive care unit. A commercial oxidizing disinfectant (potassium peroxomonosulphate 50%, sodium alkyl benzene sulphonate 15%, and sulphamic acid 5%) was introduced throughout the intensive care unit, and its use coincided with cessation of the outbreak.

Type
Concise Communications
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Depuydt, P, Benoit, D, Vogelaers, D, et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic-resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008;34:675682.CrossRefGoogle ScholarPubMed
2. Maragakis, LL, Tucker, MG, Miller, RG, Carroll, KC, Perl, TM. Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008;299:25132514.CrossRefGoogle ScholarPubMed
3. Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:22332239.CrossRefGoogle ScholarPubMed
4. Wisplinghoff, H, Schmitt, R, Wohrmann, A, Stefanik, D, Seifert, H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii . J Hosp Infect 2007;66:174181.CrossRefGoogle ScholarPubMed
5. Kawamura-Sato, K, Wachino, J, Kondo, T, Ito, H, Arakawa, Y. Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material. J Antimicrob Chemother 2008;61:568576.CrossRefGoogle ScholarPubMed
6. Rodriguez-Bano, J, Marti, S, Soto, S, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008;14:276278.CrossRefGoogle ScholarPubMed
7. Hernndez, A, Martro, E, Matas, L, Martin, M, Ausina, V. Assessment of in vitro efficacy of 1% Virkon against bacteria, fungi, viruses and spores by means of AFNOR guidelines. J Hosp Infect 2000;46:203209.Google ScholarPubMed
8. Peleg, AY, Seifert, H, Paterson, DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538582.CrossRefGoogle ScholarPubMed